IBC Dates, Deadlines, and Fees

IBC Meeting Dates

The IBC may choose to review any submission at a convened Meeting. These submissions are designated for Full Committee Review (FCR). All new submissions involving recombinant nucleic acid molecules are designated for FCR. Non-recombinant submissions of increased complexity and concern have a higher likelihood of being designated for FCR.

When to Submit

Protocols must undergo a pre-review procedure that includes an assessment for completeness and confirmation of content prior to being sent to the Committee for review. It is recommended that complex protocols such as those describing multiple aims, RG-2 vectors, pathogenic agents, or novel procedures and technology be submitted at least 4 weeks prior to the meeting. Researchers are encouraged to consider splitting complex projects especially those with multiple aims into additional protocol(s) when possible, to facilitate a faster review process. Protocols that have not sufficiently advanced in the review process may be withheld from the agenda until it has advanced in review process. If you have funding pending IBC approval, please contact the IBC. RSC personnel will work with you to help facilitate the protocol submission, review and approval process.

Scheduled IBC Meeting Dates

2021 Scheduled IBC Meeting Dates	2022 Scheduled IBC Meeting Dates
July 27, 2021	January 25, 2022
No meeting in August	No meeting in February
September 7, 2021	March 8, 2022
October 12, 2021	April 12, 2022
November 9, 2021	May 10, 2022
December 7, 2021	June 14, 2022
	July 26, 2022
	No meeting in August
	September 13, 2022
	October 11, 2022
	November 8, 2022
	December 13, 2022

At the discretion of the IBC, scheduled meeting dates may change or additional meeting dates may be added to the schedule.

IBC Fees

Fees are assessed in the following situations:

Industry sponsored clinical trials submitted for review and approval by the IBC.
Research involving recombinant nucleic acid molecules, hazardous materials, infectious agents, or toxins conducted in UT facilities on behalf of non-UT institutions when there is no award to UT.

IBC Action	Fee
Initial Convened IBC Review	$2,500
Tri-Annual Renewal Review	$2,500
Amendment Review	$700
Closure	$100